COMMUNIQUÉS West-GlobeNewswire

ObsEva SA Announces Completion of Patient Recruitment in PRIMROSE 1 Phase 3 Clinical Trial of Linzagolix for the Treatment of Heavy Menstrual Bleeding Associated with Uterine Fibroids
08/07/2019
Geneva, Switzerland and Boston, MA – July 8, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Acacia Pharma Plans to Resubmit the BARHEMSYS® NDA in Q3 2019
08/07/2019
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and Indianapolis, US – 8 July 2019: Acacia Pharma Group plc (“Acacia Pharma” or [...]
Priority Review Granted to BeiGene’s Supplemental New Drug Application in China for Tislelizumab in Urothelial Carcinoma
08/07/2019
BEIJING, China and CAMBRIDGE, Mass., July 07, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Tetra Bio-Pharma Comments on Recent Trading Activity at the Request of IIROC
05/07/2019
ORLEANS, Ontario, July 05, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") a bio-pharmaceutical multifaceted corporation with its primary focus in cannabinoid‑based drug discovery and [...]
Shineco, Inc. Receives Notice of Nasdaq Non-Compliance Due to Delayed Annual Meeting
05/07/2019
BEIJING, July 05, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; Nasdaq: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and [...]
Acer Therapeutics Announces Restructuring and Update on Pipeline Programs
05/07/2019
Restructuring expected to extend cash runway through end of 2020 Acer plans to discuss EDSIVO™ CRL with FDA and will continue to advance additional pipeline products NEWTON, Mass., July 05, 2019 (GLOBE NEWSWIRE) -- Acer [...]
Novelion Therapeutics Receives Delisting Notifications
05/07/2019
VANCOUVER, British Columbia, July 05, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]
TYME Presents Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends in Patients with Advanced Pancreatic Cancer
05/07/2019
In this poor prognosis population, SM-88 demonstrated median overall survival (OS) of 6.4 months as of April 25, 2019 Efficacy indicators showed strong correlation with greater overall survival (OS). These indicators [...]
Veterans Affairs San Diego Healthcare System Receives Spinal Cord Rehabilitation Exoskeleton from SoldierStrong
05/07/2019
SAN DIEGO, July 05, 2019 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit organization dedicated to providing advanced medical technologies to help injured veterans lead full lives, donated an Indego Therapy [...]
Oasmia and Arwidsro have solved outstanding balances and Arwidsro increases its investment in Oasmia
05/07/2019
Today an agreement has been made between Oasmia and its largest shareholder Arwidsro. The agreement is made to solve earlier unclear balances and to support the planned commercialization of Oasmia with more capital. [...]
NoorLine launches a free 24 hour Culturally Sensitive online therapy website
05/07/2019
DETROIT, July 05, 2019 (GLOBE NEWSWIRE) -- NoorLine, a free anonymous distress line launches out of Detroit this week to help bring 24 hour peer to peer anonymous emotional support to distressed individuals worldwide. [...]
B.C. youth Samir Dattani to represent Canadians with type 1 diabetes in Washington, D.C.
04/07/2019
Samir will be available for interviews on location from Washington throughout the event (July 8-10) VANCOUVER, British Columbia, July 04, 2019 (GLOBE NEWSWIRE) -- 16-year-old Samir Dattani, a long-time type 1 diabetes [...]
AB Science : Validation of the AB8939 clinical development plan through regulatory authority Scientific Advice procedure
04/07/2019
Paris, July 04, 2019, 7pm Validation of the AB8939 clinical development plan through regulatory authority Scientific Advice procedure AB Science will host a live webcast on 8 July to present the validated clinical plan [...]
AB Science : Validation du plan de développement clinique de la molécule AB8939 suite à la procédure réglementaire de Scientific Advice
04/07/2019
Paris, 4 juillet 2019, 19h Validation du plan de développement clinique de la molécule AB8939 suite à la procédure réglementaire de Scientific Advice AB Science tiendra une conférence web le 8 juillet afin de présenter [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2019
04/07/2019
Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2019 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2019
04/07/2019
Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2019 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Charenton- [...]
Infant Bacterial Therapeutics has recruited the first patient in the pivotal Phase III clinical study
04/07/2019
IBT has recruited the first patient in the Phase III pivotal clinical study, The Connection Study. The development program for IBP-9414, of which The Connection Study is the final planned clinical study, has now been [...]
Ascent Industries Announces That Garett Senez Joins as Vice President Marketing
04/07/2019
VANCOUVER, British Columbia, July 04, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. (CSE: ASNT) ("Ascent") announces Garett Senez is joining the new Management Team to lead Marketing efforts for the company. Garett [...]
Blueberries Announces DTC Eligibility of its Common Shares in the United States
04/07/2019
TORONTO, July 04, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. ( CSE: BBM ) (OTCQB: BBRRF) (FRA: 1OA) (" Blueberries " or the " Company "), a leading Latin American licensed producer of medicinal cannabis and [...]

Pages